American Cancer Society, 2014, Cancer Facts & Figures 2014, 4
Trichopoulos, 2008, Int J Cancer, 122, 481, 10.1002/ijc.23303
Harris, 2007, J Clin Oncol, 25, 5287, 10.1200/JCO.2007.14.2364
Fingleton, 2006, Front Biosci, 11, 479, 10.2741/1811
Pellikainen, 2004, Clin Cancer Res, 10, 7621, 10.1158/1078-0432.CCR-04-1061
Brew, 2000, Biochim Biophys Acta, 1477, 267, 10.1016/S0167-4838(99)00279-4
Baker, 1998, J Clin Invest, 101, 1478, 10.1172/JCI1584
Talvensaari-Mattila, 2005, Breast Cancer Res Treat, 89, 29, 10.1007/s10549-004-1006-8
Lin, 2002, J Mammary Gland Biol Neoplasia, 7, 147, 10.1023/A:1020399802795
Sobin, 2011, TNM classification of malignant tumours, 7, 181
Jemal, 2003, CA Cancer J Clin, 53, 5, 10.3322/canjclin.53.1.5
Ławicki, 2012, Folia Histochem Cytobiol, 50, 213, 10.5603/FHC.2012.0030
Ławicki, 2010, Pol Merkur Lekarski, 28, 354
Ławicki, 2012, Growth Factors, 30, 357, 10.3109/08977194.2012.724407
Czygier, 2009, Przegl Lek, 66, 433
Vasiliades, 2012, Int J Biol Markers, 27, e186, 10.5301/JBM.2012.9348
Bahar, 2010, Asian Pac J Cancer Prev, 11, 709
McDermott, 2002, Eur Cytokine Netw, 13, 121
Kaciński, 1995, Ann Med, 27, 79, 10.3109/07853899509031941
Scholl, 1996, Breast Cancer Res Treat, 39, 275, 10.1007/BF01806155
Visse, 2003, Circ Res, 92, 827, 10.1161/01.RES.0000070112.80711.3D
Giannelli, 2004, Int J Cancer, 109, 782, 10.1002/ijc.20009
Jinga, 2006, J Cell Mol Med, 10, 499, 10.1111/j.1582-4934.2006.tb00415.x
Wu, 2008, Int J Cancer, 122, 2050, 10.1002/ijc.23337
Voorzanger-Rousselot, 2006, Br J Cancer, 95, 506, 10.1038/sj.bjc.6603285
Ławicki, 2013, Growth Factors, 31, 98, 10.3109/08977194.2013.797900
Ławicki, 2006, Clin Chim Acta, 371, 112, 10.1016/j.cca.2006.02.033
Iwata, 1996, Jpn J Cancer Res, 87, 602, 10.1111/j.1349-7006.1996.tb00266.x
McCarthy, 1999, Int J Cancer, 84, 44, 10.1002/(SICI)1097-0215(19990219)84:1<44::AID-IJC9>3.0.CO;2-P
